Literature DB >> 1899355

Diagnostic imaging in cancer care. The role of cost/benefit analysis.

R G Evens1.   

Abstract

As the cost of medical care rises, there is increasing need to analyze the costs and benefits of diagnostic imaging. A review of previous research shows reasonable success at defining costs and the ability to identify safety and risk, but limited data on defining benefits in economic terms. The technology to analyze costs and benefits is improving, and satisfactory research protocols and methods have recently become generally accepted. While research studies to determine costs and benefits or efficacy are themselves costly, time consuming, and difficult to perform in clinical practice, the wise allocation of medical resources in the US requires physicians in all specialties to evaluate the technology when we are responsible for its use.

Entities:  

Mesh:

Year:  1991        PMID: 1899355     DOI: 10.1002/1097-0142(19910215)67:4+<1245::aid-cncr2820671522>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Tumor imaging protocols: problems and challenges.

Authors:  Mervyn D Cohen
Journal:  Pediatr Radiol       Date:  2003-07-10

Review 2.  Does immunoscintigraphy serve clinical needs effectively? Is there a future for radioimmunotherapy?

Authors:  J F Chatal; P Peltier; M Bardiès; A Chétanneau; P Thedrez; A Faivre-Chauvet; J F Gestin
Journal:  Eur J Nucl Med       Date:  1992

3.  Finding cancer in primary care outpatients with low back pain: a comparison of diagnostic strategies.

Authors:  J D Joines; R A McNutt; T S Carey; R A Deyo; R Rouhani
Journal:  J Gen Intern Med       Date:  2001-01       Impact factor: 5.128

4.  Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin's disease.

Authors:  O Landgren; U Axdorph; H Jacobsson; B Johansson; G Grimfors; M Björkholm
Journal:  Med Oncol       Date:  2000-08       Impact factor: 3.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.